SCHEMBL6568595

SCHEMBL6568595

COc1ccc(NC(=O)NC2CC2c2ccccc2)cc1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.59
EPHX2 P34913 3/20 0.55
IDH1 O75874 1/20 0.52
MET P08581 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
EGFR P00533 1/20 0.46
KDM1A O60341 4/20 0.46
NPC1 O15118 2/20 0.46
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
GAA P10253 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
ROCK2 O75116 1/20 0.45
ROCK1 Q13464 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6565673 0.87 CNR1 (0.65) CNR1EPHX2IDH1METSMN1; SMN2
SCHEMBL6567565 0.75 CNR1 (0.71) CNR1EPHX2IDH1METSMN1; SMN2
SCHEMBL6567546 0.75 CNR1 (0.64) CNR1EPHX2IDH1METSMN1; SMN2
SCHEMBL22834265 0.75 CNR1 (1.00) CNR1EPHX2IDH1METSMN1; SMN2
SCHEMBL22834156 0.75 CNR1 (1.00) CNR1EPHX2IDH1METSMN1; SMN2
SCHEMBL22834153 0.75 CNR1 (1.00) CNR1EPHX2IDH1METSMN1; SMN2
SCHEMBL6567236 0.74 CNR1 (0.62) CNR1EPHX2IDH1METSMN1; SMN2
SCHEMBL6567627 0.74 CNR1 (0.59) CNR1EPHX2IDH1SMN1; SMN2NPSR1
SCHEMBL6568628 0.74 NPC1 (0.65) EPHX2SMN1; SMN2NPC1MEN1ALDH1A1
SCHEMBL6565578 0.74 EPHX2 (0.61) EPHX2KDM1AMAOAMAOBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed